ALBIREO PHARMA INC's ticker is and the CUSIP is 01345P956. A total of 1 filers reported holding ALBIREO PHARMA INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $149,109 | +101.5% | 6,900 | +81.6% | 0.00% | – |
| Q3 2022 | $74,000 | -1.3% | 3,800 | 0.0% | 0.00% | – |
| Q2 2022 | $75,000 | -35.3% | 3,800 | -24.0% | 0.00% | – |
| Q4 2021 | $116,000 | -79.5% | 5,000 | -72.4% | 0.00% | -100.0% |
| Q3 2021 | $565,000 | -58.6% | 18,100 | -53.4% | 0.00% | -50.0% |
| Q2 2021 | $1,365,000 | -0.2% | 38,800 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $1,368,000 | -47.4% | 38,800 | -44.1% | 0.00% | -60.0% |
| Q4 2020 | $2,603,000 | -31.5% | 69,400 | -39.1% | 0.01% | -58.3% |
| Q3 2020 | $3,801,000 | – | 113,900 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |